FDA Approved: TECVAYLI — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

The FDA approved Janssen Biotech's supplemental application for TECVAYLI (teclistamab-cqyv), resulting in an updated/expanded labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

SUPPL AP for TECVAYLI (TECLISTAMAB-CQYV)